Human Immunodeficiency Virus-Associated Pulmonary Arterial Hypertension Considerations for Pulmonary Vascular Diseases in the Developing World

被引：35
|
作者：
Butrous, Ghazwan [1 ,2 ]
机构：
[1] Univ Kent, Sch Pharm, Canterbury CT2 7NJ, Kent, England
[2] Pulm Vasc Res Inst, Canterbury, Kent, England
来源：
CIRCULATION | 2015年 / 131卷 / 15期
关键词：
HIV; pulmonary circulation; pulmonary hypertension; HIV-INFECTED PATIENTS; ACTIVE ANTIRETROVIRAL THERAPY; ENDOTHELIAL-CELLS; CARDIOVASCULAR-DISEASES; ASYMMETRIC DIMETHYLARGININE; VENOOCCLUSIVE DISEASE; PROTEASE INHIBITORS; PROGNOSTIC-FACTORS; OXIDATIVE STRESS; NATURAL-HISTORY;
D O I：
10.1161/CIRCULATIONAHA.114.006978
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1361 / 1370
页数：10
相关论文
共 50 条
  • [21] Human immunodeficiency viruses and their effect on the pulmonary vascular bed
    Butrous, Ghazwan
    AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2021, 321 (06) : L1062 - L1066
  • [22] Human Immunodeficiency Virus-Associated Lung Malignancies
    Lambert, Allison A.
    Merlo, Christian A.
    Kirk, Gregory D.
    CLINICS IN CHEST MEDICINE, 2013, 34 (02) : 255 - +
  • [23] Pathogenesis and treatment of human immunodeficiency virus-associated cytomegalovirus retinitis
    Tan, Suiyi
    Liu, Shuwen
    Jiang, Shibo
    FUTURE VIROLOGY, 2011, 6 (04) : 503 - 520
  • [24] Human immunodeficiency virus-1 transgene expression increases pulmonary vascular resistance and exacerbates hypoxia-induced pulmonary hypertension development
    Porter, Kristi M.
    Walp, Erik R.
    Elms, Shawn C.
    Raynor, Robert
    Mitchell, Patrick O.
    Guidot, David M.
    Sutliff, Roy L.
    PULMONARY CIRCULATION, 2013, 3 (01) : 58 - 67
  • [25] Pulmonary arterial hypertension associated with connective tissue diseases: A review focusing on distinctive clinical aspects
    Kato, Masaru
    Atsumi, Tatsuya
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2018, 48 (02)
  • [26] Noninfectious Pulmonary Complications of Human Immunodeficiency Virus Infection
    Staitieh, Bashar
    Guidot, David M.
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2014, 348 (06) : 502 - 511
  • [27] Developing treatments for pulmonary arterial hypertension
    Wilkins, Martin R.
    PULMONARY CIRCULATION, 2013, 3 (01) : 156 - 159
  • [28] Pulmonary Arterial Enlargement in Well-Treated Persons With Human Immunodeficiency Virus
    Knudsen, Andreas D.
    Ronit, Andreas
    Kristensen, Thomas
    Thomsen, Magda Teresa
    Lebech, Anne-Mette
    Cuong, Michael Huy
    Sigvardsen, Per Ejlstrup
    Kuehl, Jorgen Tobias
    Fuchs, Andreas
    Kober, Lars
    Lundgren, Jens
    Vestbo, Jorgen
    Kofoed, Klaus F.
    Nielsen, Susanne D.
    JOURNAL OF INFECTIOUS DISEASES, 2021, 223 (01) : 94 - 100
  • [29] Pulmonary hypertension and human immunodeficiency virus infection: epidemiology, pathogenesis, and clinical approach
    Cicalini, S.
    Almodovar, S.
    Grilli, E.
    Flores, S.
    CLINICAL MICROBIOLOGY AND INFECTION, 2011, 17 (01) : 25 - 33
  • [30] Survival in rheumatoid arthritis-associated pulmonary arterial hypertension compared with idiopathic pulmonary arterial hypertension
    Sadeghi, Saghar
    Granton, John T.
    Akhavan, Pooneh
    Pasarikovski, Christopher R.
    Roos, Adrienne M.
    Thenganatt, John
    Moric, Jakov
    Johnson, Sindhu R.
    RESPIROLOGY, 2015, 20 (03) : 481 - 487
12345